Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

por Bièche, I, Olivi, M, Noguès, C, Vidaud, M, Lidereau, R
Publicado 2002

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

por Curmi, P A, Noguès, C, Lachkar, S, Carelle, N, Gonthier, M-P, Sobel, A, Lidereau, R, Bièche, I
Publicado 2000

Cell Death Mechanisms in Tumoral and Non-Tumoral Human Cell Lines Triggered by Photodynamic Treatments: Apoptosis, Necrosis and Parthanatos

por Soriano, J., Mora-Espí, I., Alea-Reyes, M. E., Pérez-García, L., Barrios, L., Ibáñez, E., Nogués, C.
Publicado 2017

Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

por Rookus, MA, Brohet, RM, Andrieu, N, Antoniou, AC, Chang-Claude, J, Easton, DF, Peock, S, Noguès, C, van Leeuwen, FE, Goldgar, DE
Publicado 2005

Low-dose ionizing radiation significantly increases the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study (IBCCS)

por Van Leeuwen, FE, Andrieu, N, Easton, DF, Chang-Claude, J, Brohet, R, Cardis, E, Antoniou, AC, Peock, S, Nogues, C, Rookus, MA, Goldgar, DE
Publicado 2005

Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer

por Brédart, A, Kop, J L, DePauw, A, Caron, O, Sultan, S, Leblond, D, Fajac, A, Buecher, B, Gauthier-Villars, M, Noguès, C, Flahault, C, Stoppa-Lyonnet, D, Dolbeault, S
Publicado 2013

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody

por Liew, A., Baustian, C., Thomas, D., Vaughan, E., Sanz-Nogués, C., Creane, M., Chen, X., Alagesan, S., Owens, P., Horan, J., Dockery, P., Griffin, M. D., Duffy, A., O’Brien, T.
Publicado 2018

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

por Sinilnikova, O M, Antoniou, A C, Simard, J, Healey, S, Léoné, M, Sinnett, D, Spurdle, A B, Beesley, J, Chen, X, Greene, M H, Loud, J T, Lejbkowicz, F, Rennert, G, Dishon, S, Andrulis, I L, Domchek, S M, Nathanson, K L, Manoukian, S, Radice, P, Konstantopoulou, I, Blanco, I, Laborde, A L, Durán, M, Osorio, A, Benitez, J, Hamann, U, Hogervorst, F B L, van Os, T A M, Gille, H J P, Peock, S, Cook, M, Luccarini, C, Evans, D G, Lalloo, F, Eeles, R, Pichert, G, Davidson, R, Cole, T, Cook, J, Paterson, J, Brewer, C, Hughes, D J, Coupier, I, Giraud, S, Coulet, F, Colas, C, Soubrier, F, Rouleau, E, Bièche, I, Lidereau, R, Demange, L, Nogues, C, Lynch, H T, Schmutzler, R K, Versmold, B, Engel, C, Meindl, A, Arnold, N, Sutter, C, Deissler, H, Schaefer, D, Froster, U G, Aittomäki, K, Nevanlinna, H, McGuffog, L, Easton, D F, Chenevix-Trench, G, Stoppa-Lyonnet, D
Publicado 2009